PBRM1 deletion
|
RCC
|
PBRM1 deletion
|
RCC
|
atezolizumab Sensitive: C3 – Early Trials
|
atezolizumab Sensitive: C3 – Early Trials
|
PBRM1 deletion
|
RCC
|
PBRM1 deletion
|
RCC
|
nivolumab Sensitive: C3 – Early Trials
|
nivolumab Sensitive: C3 – Early Trials
|
PBRM1 deletion
|
RCC
|
PBRM1 deletion
|
RCC
|
sunitinib Resistant: C4 – Case Studies
|
sunitinib Resistant: C4 – Case Studies
|